Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016

被引:0
作者
Khalil, Ibrahim A. [1 ]
Troeger, Christopher [1 ]
Blacker, Brigette F. [1 ]
Rao, Puja C. [1 ]
Brown, Alexandria [1 ]
Atherly, Deborah E. [2 ]
Brewer, Thomas G. [5 ]
Engmann, Cyril M. [3 ,5 ,7 ]
Houpt, Eric R. [10 ]
Kang, Gagandeep [11 ]
Kotloff, Karen L. [12 ,13 ,14 ]
Levine, Myron M. [13 ]
Luby, Stephen P. [15 ]
MacLennan, Calman A. [16 ]
Pan, William K. [1 ,17 ]
Pavlinac, Patricia B. [5 ]
Platts-Mills, James A.
Qadri, Firdausi [18 ]
Riddle, Mark S. [19 ]
Ryan, Edward T. [20 ,21 ,22 ]
Shoultz, David A. [4 ,5 ,6 ,23 ]
Steele, A. Duncan [16 ]
Walson, Judd L. [5 ,7 ,8 ,9 ]
Sanders, John W. [24 ]
Mokdad, Ali H. [1 ]
Murray, Christopher J. L. [1 ]
Hay, Simon I. [1 ,25 ]
Reiner, Robert C., Jr. [1 ]
机构
[1] Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA
[2] PATH, Ctr Vaccine Innovat & Access, Seattle, WA USA
[3] PATH, Maternal Newborn Child Hlth Nutr, Seattle, WA USA
[4] PATH, Drug Dev, Seattle, WA USA
[5] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA
[6] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA
[7] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
[8] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[9] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA 98195 USA
[10] Univ Virginia, Div Infect Dis & Int Hlth, Charlottesville, VA USA
[11] Translat Hlth Sci & Technol Inst, Faridabad, India
[12] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
[13] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[14] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA
[15] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
[16] Bill & Melinda Gates Fdn, Enter & Diarrheal Dis, Seattle, WA USA
[17] Duke Univ, Duke Global Hlth Inst, Durham, NC USA
[18] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Dhaka, Bangladesh
[19] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA
[20] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA
[21] Harvard Med Sch, Dept Med, Boston, MA USA
[22] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[23] Seattle Univ, Albers Sch Business & Econ, Seattle, WA 98122 USA
[24] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
[25] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford, England
关键词
EARLY-CHILDHOOD DIARRHEA; RESEARCH-AND-DEVELOPMENT; DEVELOPING-COUNTRIES; ENTERIC MULTICENTER; CHILDREN; VACCINE; ETIOLOGY; COMMUNITY; MILITARY; INFANTS;
D O I
10.1016/S1473-3099(18)30475-4
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Shigella and enterotoxigenic Escherichia coli (ETEC) are bacterial pathogens that are frequently associated with diarrhoeal disease, and are a significant cause of mortality and morbidity worldwide. The Global Burden of Diseases, Injuries, and Risk Factors study 2016 (GBD 2016) is a systematic, scientific effort to quantify the morbidity and mortality due to over 300 causes of death and disability. We aimed to analyse the global burden of shigella and ETEC diarrhoea according to age, sex, geography, and year from 1990 to 2016. Methods We modelled shigella and ETEC-related mortality using a Bayesian hierarchical modelling platform that evaluates a wide range of covariates and model types on the basis of vital registration and verbal autopsy data. We used a compartmental meta-regression tool to model the incidence of shigella and ETEC, which enforces an association between incidence, prevalence, and remission on the basis of scientific literature, population representative surveys, and health-care data. We calculated 95% uncertainty intervals (UIs) for the point estimates. Findings Shigella was the second leading cause of diarrhoeal mortality in 2016 among all ages, accounting for 212 438 deaths (95% UI 136 979-326 913) and about 13.2% (9. 2-17. 4) of all diarrhoea deaths. Shigella was responsible for 63 713 deaths (41191-93 611) among children younger than 5 years and was frequently associated with diarrhoea across all adult age groups, increasing in elderly people, with broad geographical distribution. ETEC was the eighth leading cause of diarrhoea mortality in 2016 among all age groups, accounting for 51 186 deaths (26 757-83 064) and about 3.2% (1. 8-4 7) of diarrhoea deaths. ETEC was responsible for about 4.2% (2. 2-6. 8) of diarrhoea deaths in children younger than 5 years. Interpretation The health burden of bacterial diarrhoeal pathogens is difficult to estimate. Despite existing prevention and treatment options, they remain a major cause of morbidity and mortality globally. Additional emphasis by public health officials is needed on a reduction in disease due to shigella and ETEC to reduce disease burden. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:1229 / 1240
页数:12
相关论文
共 54 条
  • [1] [Anonymous], 2016, Am J Gastroenterol Suppl, DOI [DOI 10.1038/AJGSUP.2016.10, 10.1038/ajgsup.2016.10]
  • [2] [Anonymous], 2017, LANCET, DOI DOI 10.1016/S0140-6736(17)32152-9
  • [3] [Anonymous], 2018, World Health Organization
  • [4] Decrease in Shigellosis-related Deaths without Shigella spp.-specific Interventions, Asia
    Bardhan, Pradip
    Faruque, A. S. G.
    Naheed, Aliya
    Sack, David A.
    [J]. EMERGING INFECTIOUS DISEASES, 2010, 16 (11) : 1718 - 1723
  • [5] Travellers' diarrhoea
    Barrett, Jessica
    Brown, Mike
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [6] Status of vaccine research and development for enterotoxigenic Escherichia coli
    Bourgeois, A. Louis
    Wierzba, Thomas F.
    Walker, Richard I.
    [J]. VACCINE, 2016, 34 (26) : 2880 - 2886
  • [7] Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects
    Chakraborty, Subhra
    Harro, Clayton
    DeNearing, Barbara
    Bream, Jay
    Bauers, Nicole
    Dally, Len
    Flores, Jorge
    de Verg, Lillian Van
    Sack, David A.
    Walker, Richard
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2016, 23 (04) : 315 - 325
  • [8] SERUM ANTIBODIES TO LIPOPOLYSACCHARIDE AND NATURAL IMMUNITY TO SHIGELLOSIS IN AN ISRAELI MILITARY POPULATION
    COHEN, D
    GREEN, MS
    BLOCK, C
    ROUACH, T
    OFEK, I
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) : 1068 - 1071
  • [9] Colombara DV., 2016, The American Journal of Gastroenterology Supplements, V3, P4, DOI [DOI 10.1038/AJGSUP.2016.9, 10.1038/ajgsup.2016.9]
  • [10] Post-Infectious Sequelae of Travelers' Diarrhea
    Connor, Bradley A.
    Riddle, Mark S.
    [J]. JOURNAL OF TRAVEL MEDICINE, 2013, 20 (05) : 303 - 312